The deal grants Venus Remedies the rights to develop, register, and commercialise MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, in India. Currently, there are no approved MBL inhibitors available in the country.
Share it
Open an Account in less than 1 Min.
Need help? Call us
+91 976 976 8500
Services
Company
Get in touch
- +91 976 976 8500
- info@markettrade.live
- Pjazza Mifsud Bonnici, Marsascala, Malta
- 333, Pali Pathar, Khar West, Mumbai, Maharashtra 400052
Copyright © 2025 Market Trade